Eli Lilly boasts a wide range of products that serve a vast number of therapeutic areas. LLY focuses primarily on ...

In recent days, Cathie Wood’s ARK Invest has materially increased its holdings in Beam Therapeutics, adding more than 195,000 shares across its genomics-focused funds as it leans further into ...

A research team introduces a fully automated, non-destructive phenotyping platform that combines X-ray fluorescence ...

Alumis is firmly in focus after announcing positive topline results from two Phase 3 trials (ONWARD1 and ONWARD2) evaluating envudeucitinib , its next-generation oral TYK2 inhibitor, in ...

Pole Star Global, a world leader in maritime intelligence and regulatory compliance solutions, today announced the launch of the Maritime Transparency Index (MTI) -- a machine learning-powered risk ...

Guardant co-CEO Helmy Eltoukhy says the shift to personalized treatment and earlier diagnosis is here at the WIRED Health ...

Brelyon Visual Engine uses NIMs capabilities along with real-time shader programming to extract data across different ...

In the swiftly evolving field of artificial intelligence (AI), the technology's capability to revolutionize care processes in ...

HIV hijacks SRRM2 to enlarge nuclear speckles, stabilizing CPSF6 puncta and promoting efficient viral replication.

Many of us like to think that we’re fairly smart. But it can be a very humbling experience when you’re in the presence of ...

Hitachi, Ltd. (TSE:6501, "Hitachi") today introduced HMAX by Hitachi at CES 2026. HMAX by Hitachi is a suite of next-generation solutions that brings the power of AI to social infrastructure. By ...

We’re seeing major investors put serious money into AI startups, which is fueling a wave of new ideas and technologies. This ...